Healio: First patient dosed in phase 2 study of hypoxic ischemic encephalopathy drug
First patient dosed in phase 2 study of hypoxic ischemic encephalopathy drug
Business Wire: ReAlta Life Sciences Doses First Patient in Phase 2 STAR-Study of RLS-0071 for Hypoxic Ischemic Encephalopathy in Newborns
ReAlta Life Sciences Doses First Patient in Phase 2 STAR-Study of RLS-0071 for Hypoxic Ischemic Encephalopathy in Newborns
ascopubs.org: Tumor Angiogenic and Hypoxic Profiles Predict Radiographic Response and Survival in Malignant Astrocytoma Patients Treated With Bevacizumab and Irinotecan
Tumor Angiogenic and Hypoxic Profiles Predict Radiographic Response and Survival in Malignant Astrocytoma Patients Treated With Bevacizumab and Irinotecan
Healthcare information and symptom checker for patients and professionals. Book your GP appointment or order your medication online with Patient.
The Patient Health Questionnaire (PHQ-9) is an easy-to-use patient questionnaire for screening, diagnosing, monitoring and measuring the severity of depression.